315 related articles for article (PubMed ID: 20056835)
1. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.
Hardison SE; Ravi S; Wozniak KL; Young ML; Olszewski MA; Wormley FL
Am J Pathol; 2010 Feb; 176(2):774-85. PubMed ID: 20056835
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.
Hardison SE; Herrera G; Young ML; Hole CR; Wozniak KL; Wormley FL
J Immunol; 2012 Oct; 189(8):4060-8. PubMed ID: 22984078
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
Hardison SE; Wozniak KL; Kolls JK; Wormley FL
Infect Immun; 2010 Dec; 78(12):5341-51. PubMed ID: 20921149
[TBL] [Abstract][Full Text] [Related]
4. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.
Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Wormley FL
J Immunol; 2014 Oct; 193(8):4060-71. PubMed ID: 25200956
[TBL] [Abstract][Full Text] [Related]
5. Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis.
Arora S; Hernandez Y; Erb-Downward JR; McDonald RA; Toews GB; Huffnagle GB
J Immunol; 2005 May; 174(10):6346-56. PubMed ID: 15879135
[TBL] [Abstract][Full Text] [Related]
6. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
[TBL] [Abstract][Full Text] [Related]
7. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
[TBL] [Abstract][Full Text] [Related]
8. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain.
Wormley FL; Perfect JR; Steele C; Cox GM
Infect Immun; 2007 Mar; 75(3):1453-62. PubMed ID: 17210668
[TBL] [Abstract][Full Text] [Related]
9. Role of IL-17A on resolution of pulmonary C. neoformans infection.
Wozniak KL; Hardison SE; Kolls JK; Wormley FL
PLoS One; 2011 Feb; 6(2):e17204. PubMed ID: 21359196
[TBL] [Abstract][Full Text] [Related]
10. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
[TBL] [Abstract][Full Text] [Related]
11. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans.
Arora S; Olszewski MA; Tsang TM; McDonald RA; Toews GB; Huffnagle GB
Infect Immun; 2011 May; 79(5):1915-26. PubMed ID: 21383052
[TBL] [Abstract][Full Text] [Related]
12. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.
Wozniak KL; Young ML; Wormley FL
Clin Vaccine Immunol; 2011 May; 18(5):717-23. PubMed ID: 21450975
[TBL] [Abstract][Full Text] [Related]
13. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans.
Müller U; Stenzel W; Köhler G; Werner C; Polte T; Hansen G; Schütze N; Straubinger RK; Blessing M; McKenzie AN; Brombacher F; Alber G
J Immunol; 2007 Oct; 179(8):5367-77. PubMed ID: 17911623
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of IL-4 receptor-α-dependent alternatively activated macrophages is sufficient to confer resistance against pulmonary cryptococcosis despite an ongoing T(h)2 response.
Müller U; Stenzel W; Piehler D; Grahnert A; Protschka M; Köhler G; Frey O; Held J; Richter T; Eschke M; Kamradt T; Brombacher F; Alber G
Int Immunol; 2013 Aug; 25(8):459-70. PubMed ID: 23532373
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
[TBL] [Abstract][Full Text] [Related]
16. TNF-α-Producing
Fa Z; Xu J; Yi J; Sang J; Pan W; Xie Q; Yang R; Fang W; Liao W; Olszewski MA
Front Immunol; 2019; 10():1725. PubMed ID: 31404168
[TBL] [Abstract][Full Text] [Related]
17. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection.
Wozniak KL; Hole CR; Yano J; Fidel PL; Wormley FL
Microbiology (Reading); 2014 Jul; 160(Pt 7):1440-1452. PubMed ID: 24760968
[TBL] [Abstract][Full Text] [Related]
18. Disruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection.
Xu J; Eastman AJ; Flaczyk A; Neal LM; Zhao G; Carolan J; Malachowski AN; Stolberg VR; Yosri M; Chensue SW; Curtis JL; Osterholzer JJ; Olszewski MA
mBio; 2016 Jul; 7(4):. PubMed ID: 27406560
[TBL] [Abstract][Full Text] [Related]
19. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis.
Chen GH; Olszewski MA; McDonald RA; Wells JC; Paine R; Huffnagle GB; Toews GB
Am J Pathol; 2007 Mar; 170(3):1028-40. PubMed ID: 17322386
[TBL] [Abstract][Full Text] [Related]
20. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide.
Rivera J; Mukherjee J; Weiss LM; Casadevall A
J Immunol; 2002 Apr; 168(7):3419-27. PubMed ID: 11907100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
